SI0854146T1 - Substituted 4-(6-fluoro-(1H)-indol-3-yl)-1,2,3,6-tetrahydropyridine for the treatment of CNS-disorders - Google Patents

Substituted 4-(6-fluoro-(1H)-indol-3-yl)-1,2,3,6-tetrahydropyridine for the treatment of CNS-disorders

Info

Publication number
SI0854146T1
SI0854146T1 SI9830009T SI9830009T SI0854146T1 SI 0854146 T1 SI0854146 T1 SI 0854146T1 SI 9830009 T SI9830009 T SI 9830009T SI 9830009 T SI9830009 T SI 9830009T SI 0854146 T1 SI0854146 T1 SI 0854146T1
Authority
SI
Slovenia
Prior art keywords
tetrahydropyridine
indol
cns
fluoro
disorders
Prior art date
Application number
SI9830009T
Other languages
English (en)
Slovenian (sl)
Inventor
John c/o Eli Lilly and Company Ltd. Fairhurst
Original Assignee
Eli Lilly And Company Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company Limited filed Critical Eli Lilly And Company Limited
Publication of SI0854146T1 publication Critical patent/SI0854146T1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
SI9830009T 1997-01-17 1998-01-14 Substituted 4-(6-fluoro-(1H)-indol-3-yl)-1,2,3,6-tetrahydropyridine for the treatment of CNS-disorders SI0854146T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9700895.7A GB9700895D0 (en) 1997-01-17 1997-01-17 Pharmaceutical compounds
EP98300249A EP0854146B1 (fr) 1997-01-17 1998-01-14 4-(6-fluoro-[1H]-indole-3-yl)1,2,3,6-tetrahydropyridine substituées pour le traitement des troubles du SNC

Publications (1)

Publication Number Publication Date
SI0854146T1 true SI0854146T1 (en) 2000-10-31

Family

ID=10806121

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9830009T SI0854146T1 (en) 1997-01-17 1998-01-14 Substituted 4-(6-fluoro-(1H)-indol-3-yl)-1,2,3,6-tetrahydropyridine for the treatment of CNS-disorders

Country Status (29)

Country Link
US (1) US20010053783A1 (fr)
EP (1) EP0854146B1 (fr)
JP (1) JPH10204090A (fr)
KR (1) KR20000070221A (fr)
AR (1) AR011422A1 (fr)
AT (1) ATE190617T1 (fr)
AU (1) AU5569298A (fr)
CA (1) CA2227132A1 (fr)
CZ (1) CZ290318B6 (fr)
DE (1) DE69800092T2 (fr)
DK (1) DK0854146T3 (fr)
EA (1) EA001469B1 (fr)
ES (1) ES2144888T3 (fr)
GB (1) GB9700895D0 (fr)
GR (1) GR3033316T3 (fr)
HU (1) HUP0000854A3 (fr)
ID (1) ID21920A (fr)
IL (1) IL129647A (fr)
NO (1) NO993372D0 (fr)
NZ (1) NZ335493A (fr)
PE (1) PE99399A1 (fr)
PL (1) PL334569A1 (fr)
PT (1) PT854146E (fr)
SI (1) SI0854146T1 (fr)
SV (1) SV1998000088A (fr)
TR (1) TR199901583T2 (fr)
TW (1) TW396156B (fr)
WO (1) WO1998031686A1 (fr)
ZA (1) ZA98300B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0897921A1 (fr) * 1997-08-22 1999-02-24 Eli Lilly And Company Limited Dérivés de benzothiadiazinyl-indole et leur utilisation comme ligands des récepteurs de la sérotonine
GB9825413D0 (en) 1998-11-19 1999-01-13 Lilly Co Eli Pharmaceutical compounds
GB9903784D0 (en) * 1999-02-18 1999-04-14 Lilly Co Eli Pharmaceutical compounds
AR028945A1 (es) * 2000-06-19 2003-05-28 Lundbeck & Co As H Derivados de indol
KR101165996B1 (ko) 2010-04-23 2012-07-18 주식회사 녹십자 프탈라지논 유도체, 이의 제조방법 및 이를 함유하는 약학적 조성물
CN105949190B (zh) * 2016-07-04 2018-06-29 烟台凯博医药科技有限公司 一种制备1，8-萘啶及衍生物的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2662696A2 (fr) * 1989-12-13 1991-12-06 Rhone Poulenc Sante Antagonistes de la serotonine, leur preparation et medicaments les contenant.
DK158590D0 (da) * 1990-07-02 1990-07-02 Lundbeck & Co As H Indolderivater
FR2675801A1 (fr) * 1991-04-24 1992-10-30 Rhone Poulenc Rorer Sa Piperidines, leur preparation et les medicaments les contenant.
DE19500689A1 (de) * 1995-01-12 1996-07-18 Merck Patent Gmbh Indolpiperidin-Derivate
US5576321A (en) * 1995-01-17 1996-11-19 Eli Lilly And Company Compounds having effects on serotonin-related systems

Also Published As

Publication number Publication date
WO1998031686A1 (fr) 1998-07-23
IL129647A0 (en) 2000-02-29
PL334569A1 (en) 2000-03-13
NO993372L (no) 1999-07-08
EP0854146B1 (fr) 2000-03-15
DE69800092D1 (de) 2000-04-20
GB9700895D0 (en) 1997-03-05
AR011422A1 (es) 2000-08-16
IL129647A (en) 2002-02-10
CZ151099A3 (cs) 1999-09-15
HUP0000854A3 (en) 2002-06-28
US20010053783A1 (en) 2001-12-20
DE69800092T2 (de) 2000-09-14
CA2227132A1 (fr) 1998-07-17
ATE190617T1 (de) 2000-04-15
NO993372D0 (no) 1999-07-08
EP0854146A1 (fr) 1998-07-22
CZ290318B6 (cs) 2002-07-17
GR3033316T3 (en) 2000-09-29
EA199900667A1 (ru) 2000-02-28
AU5569298A (en) 1998-08-07
PT854146E (pt) 2000-08-31
ID21920A (id) 1999-08-12
ZA98300B (en) 1998-09-10
TR199901583T2 (xx) 1999-11-22
JPH10204090A (ja) 1998-08-04
KR20000070221A (ko) 2000-11-25
EA001469B1 (ru) 2001-04-23
NZ335493A (en) 2000-09-29
PE99399A1 (es) 1999-11-11
HUP0000854A2 (hu) 2000-11-28
SV1998000088A (es) 2000-10-10
ES2144888T3 (es) 2000-06-16
DK0854146T3 (da) 2000-06-05
TW396156B (en) 2000-07-01

Similar Documents

Publication Publication Date Title
HUP0003217A3 (en) Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and 1-oxoisoindolines and pharmaceutical compositions containing them
HU9302460D0 (en) 5/20/4-(1,2-benzisothiazole-3-yl)-1-pierazinyl/ethyl/-6-chlorine-1,3-dihydro-2h-indole-2-one-hydrogen-chloride-mononhydrate
HUP0000487A3 (en) Subsituted oximes derivatives useful as neurokinin antagonists
PL338563A1 (en) Substituted derivatives of 1,2,3,4-tetrahydronaphtalene
ZA200107689B (en) 1-Arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of CNS disorders.
IL133960A0 (en) 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1h-indole derivatives
HK1032785A1 (en) Novel 3,6-hemiketals from the class of 9a-azalides
HUP0100640A3 (en) Process for the preparation of 1,4-dihydropyridines
DE69629454D1 (en) Antipsychotische 4-(1h-indolyl-1-yl)-1-substituierte piperidine derivate
IL147978A0 (en) Substituted pyrrolidin-2,3,4-trion-3-oxime derivatives useful as nmda-receptor antagonists
IL129647A0 (en) Substituted 4-(6-fluoro-(1H)-indol-3-YL)-1,2,3,6-tetrahydropyridine for the treatment of CNS-disorders
AU8970101A (en) Process for the preparation of 4,6-dimethoxy-2-(methylsulfonyl)-1,3-pyrimidine
ZA98749B (en) Compounds analogous to thalidomide from the class comprising piperidine-2,6 diones
PL328228A1 (en) 1-(pyrazol-3-yl-ethyl)-4-(indol-3-yl)-piperidines as agents influencing the central nervous system
HUP9904035A3 (en) Modified crystalline form of the r-(-)-n-(4,4-di(3-methylthien-2-yl)but-3-enyl)-nipecotic acid hydrochloride
ZA988397B (en) Process for the preparation of substituted 5,6-dihydro-2H-pyran-2-ones
GB2371543B (en) 3,3,5,5-Tetraalkyl-piperazin-2,6-dione stabilizers
PL328514A1 (en) 1,4-dihydropyridine compounds as antagonists of bradykinin
HUP0204169A3 (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines an
AU7025800A (en) Process for the preparation of 1-methyl-3-carbomethoxy-4-(4'-fluorophenyl)-piperidine
SI1192134T1 (sl) Postopki za pripravo (R)-alfa-(2,3-dimetoksifenil)-1-2-(4-fluorofenil) etil)-4-piperidinmetanola
HRP980497B1 (en) NOVEL 3,6-HEMIKETALS FROM THE CLASS OF 9a-AZALIDES
PL317916A1 (en) Novel derivative of 3,4-pyrollodicarboxylimide
PL317919A1 (en) Novel derivative of 3,4-pyrollodicarboxylimide
PL317918A1 (en) Novel derivative of 3,4-pyrollodicarboxylimide